Background: Contributing to clinical research is generally personally and professionally rewarding for urologists. The regulatory environment can seem daunting and this paper guides a new consultant through the initial steps to plan and commence a project. Objectives: The objective of this study was to guide a new consultant in planning and implementing a clinical research project by providing a detailed review on how to start and conduct a clinical project. Methods: Research committees and bodies that offer funding and help were researched thoroughly and an intensive guideline was written to help new trainees and consultants to begin and implement clinical research. Conclusions: The necessary information required to conduct and implement a clinical research project for a new consultant.
Why contribute to clinical research?
The personal rewards for clinical research are many; performing research usually necessitates up-to-date and strong reflective practice: Clinical research ensures this is the case, for you and your department. It may make you consider the practise that you had taken for granted, and it helps all staff in the department to maintain a critical and enquiring approach to their work. Junior doctors should find their work within your department more stimulating and with a greater capacity to build their CVs, thus improving recruitment and retention. 'Soft' money from commercial trials can help to pump prime funding of other projects or staff within the department. Being a principal investigator (PI) for a national trial helps consolidate clinical knowledge and enables the department to be recognised as a clinical research centre.
Well-designed clinical trials are one of the main methods used to provide robust findings for the practice of evidence-based medicine, to which we should aspire as clinicians. To achieve reproducible and credible findings, a large patient cohort is likely to be required. This will be the case, whether the study is investigating drugs, devices, diagnostic tests, surgical interventions, or even changes to patients' lifestyles. Safety issues with new treatments, particularly for novel pharmaceutical agents, should also be studied in as large a group as feasible and economically possible, to allow early identification of the safety issues and risk characterisation.
There are a number of reasons why carrying out clinical studies across a number of research sites is important. Firstly, it is the most efficient way to recruit patients to a study in a reasonable time frame. Secondly, it reduces the risk of bias occurring in the recruitment or conduct of the study, as all sites will work according to a comprehensive written protocol. Finally, the credibility of the study results will be enhanced and the findings will be more likely to be generally applicable across different localities and populations. Successful completion of a multi-site clinical study requires the enthusiastic and sustained contribution of clinicians and research staff at each site, to achieve the planned recruitment figures and collect study outcomes according to the protocol.
The frequent requirement for multiple sites, therefore, offers the opportunity for clinicians in a variety of settings to make their own contribution, often to a national or international trial.
How does this work in practice?
To give a contemporary example, the recently published UK Spontaneous Urinary Stone Passage Enabled by Drugs (SUSPEND) trial, 1 investigating the clinical usefulness of medical expulsive therapy (MET), for people with ureteric stones, was set up and run by the Centre for Healthcare Randomised Trials (CHaRT) at Aberdeen University. This included central administration and data handling, but the trial design and high sample size (> 1000 patients) required multi-site recruitment from hospitals throughout the UK. To take part, each site needed a Principal Investigator (PI), in this case a Consultant Urologist, and sufficient resource in terms of access to eligible patients, time, staff and data collection mechanisms to recruit patients to the study. The resources decided the local site target for recruitment to the study. The SUSPEND trial was publicised through the British Association of Urological Surgeons (BAUS) and its Section of Endourology, both initially and throughout the trial. Recruitment gathered pace as additional centres joined the trial responding to this publicity, by word of mouth from colleagues and by directly approaching CHaRT in Aberdeen.
I want to get involved in clinical research. What do I need to do and how do I find a list of current urology trials?
To recruit patients to studies in the UK National Health Service (NHS), you will first need to complete a Good Clinical Practice (GCP) training course, which is available through your own Trust or online at https://www.crn.nihr. ac.uk/learning-development/good-clinical-practice/.
You should then consider the area or areas of research that interest you, and for which you have access to the required patient population. To contribute effectively you will need time, organisation and help from others, including the local NHS Research and Development (R&D) Department. You are likely to need a research fellow or a clinical research team to do the day-to-day running of the trial and for the checking of regulatory aspects. If working with human tissue, there are a total of nine Human Tissue Act policies. Those relevant to your own research need to be understood and applied. Guidance and policies can be found at: https://www.hta.gov.uk/guidance-professionals/ codes-practice.
Once you have identified a study that you are interested in contributing to, you should first discuss the possibility with a representative of the trial organisers: Either the Trial Manager or the Chief Investigator (CI). Once they are keen to have your help, you should speak to your R&D department at the NHS Trust where you intend to recruit patients to the study. You will need to gain their support and help to:
Review the research proposal/main Integrated
Research Application System (IRAS) form and make a decision on whether the site is able to participate; for example, whether there is sufficient funding and staffing to run the trial locally; and 2. Complete an application through the approval system, to run the study at the site and to fill out site-specific forms. The latter are the forms required by the local CRN.
Your R&D department may advise on appropriate workshops and on training organised through the UK National Institute for Health Research (NIHR) Clinical Research Networks (CRN).
Currently the most useful list of UK clinical trials, listed by subspecialty (mostly cancer trials) can be found at the NIHR Clinical Trials Gateway website at http:// www.ukctg.nihr.ac.uk.
You can search for trials, which are offered by area of interest, geographical location or by disease; then clicking on links that give details about each individual trial and information such as contact details, for whom to approach for involvement.
For commercial industry-funded trials, generally the potential PIs are approached directly by company representatives. This is often based on successful recruitment to previous trials and an expressed interest.
The Local CRN is another agency currently in the process of establishing local research representatives from various sites. This is more focussed on benign urology research. Interested clinicians can find more information at: http://www.crn.nihr.ac.uk/renal.
Once the study has commenced at a new site, the duties of the PI include leading the trial and approaching the appropriate patients for screening and recruitment, thereby contributing effectively to the overall target recruitment for the trial.
This article is meant as a guide for those starting out in research as a consultant. Once you or your hospital has a good track record in recruiting study participants, you will likely be approached when trials are at the planning stage.
Summary
Getting involved in clinical research can often be challenging for a new consultant. The hospital's R&D department
